| Identification of a low–molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice M Cazorla, J Prémont, A Mann, N Girard, C Kellendonk, D Rognan The Journal of clinical investigation 121 (5), 1846-1857, 2011 | 392 | 2011 |
| Identification of a low–molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice M Cazorla, J Prémont, A Mann, N Girard, C Kellendonk, D Rognan The Journal of clinical investigation 121 (5), 1846-1857, 2011 | 392 | 2011 |
| Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry M Cazorla, FD de Carvalho, MO Chohan, M Shegda, N Chuhma, ... Neuron 81 (1), 153-164, 2014 | 260 | 2014 |
| Reconstituting corticostriatal network on-a-chip reveals the contribution of the presynaptic compartment to Huntington’s disease A Virlogeux, E Moutaux, W Christaller, A Genoux, J Bruyere, E Fino, ... Cell reports 22 (1), 110-122, 2018 | 178 | 2018 |
| Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice M Cazorla, A Jouvenceau, C Rose, JP Guilloux, C Pilon, A Dranovsky, ... PloS one 5 (3), e9777, 2010 | 116 | 2010 |
| Striatal D2 receptors regulate dendritic morphology of medium spiny neurons via Kir2 channels M Cazorla, M Shegda, B Ramesh, NL Harrison, C Kellendonk Journal of Neuroscience 32 (7), 2398-2409, 2012 | 115 | 2012 |
| TrkB inhibition as a therapeutic target for CNS-related disorders F Boulle, G Kenis, M Cazorla, M Hamon, HWM Steinbusch, L Lanfumey, ... Progress in neurobiology 98 (2), 197-206, 2012 | 87 | 2012 |
| An integrated microfluidic/microelectrode array for the study of activity-dependent intracellular dynamics in neuronal networks E Moutaux, B Charlot, A Genoux, F Saudou, M Cazorla Lab on a Chip 18 (22), 3425-3435, 2018 | 84 | 2018 |
| Neuronal network maturation differently affects secretory vesicles and mitochondria transport in axons E Moutaux, W Christaller, C Scaramuzzino, A Genoux, B Charlot, ... Scientific reports 8 (1), 13429, 2018 | 59 | 2018 |
| Balancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and disease M Cazorla, UJ Kang, C Kellendonk Movement Disorders 30 (7), 895-903, 2015 | 57 | 2015 |
| Systemic delivery of a brain-penetrant TrkB antagonist reduces cocaine self-administration and normalizes TrkB signaling in the nucleus accumbens and prefrontal cortex MMM Verheij, LF Vendruscolo, L Caffino, G Giannotti, M Cazorla, ... Journal of Neuroscience 36 (31), 8149-8159, 2016 | 44 | 2016 |
| Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor M Cazorla, JM Arrang, J Prémont British journal of pharmacology 162 (4), 947-960, 2011 | 40 | 2011 |
| Cyclotraxin-B, a new TrkB antagonist, and glial blockade by propentofylline, equally prevent and reverse cold allodynia induced by BDNF or partial infraorbital nerve … L Constandil, M Goich, A Hernández, L Bourgeais, M Cazorla, M Hamon, ... The Journal of Pain 13 (6), 579-589, 2012 | 31 | 2012 |
| Brain-derived neurotrophic factor stimulates growth of pituitary melanotrope cells in an autocrine way M Kuribara, MW Hess, M Cazorla, EW Roubos, WJJM Scheenen, ... General and comparative endocrinology 170 (1), 156-161, 2011 | 14 | 2011 |
| Alix is required for activity-dependent bulk endocytosis at brain synapses MH Laporte, KI Chi, LC Caudal, N Zhao, Y Schwarz, M Rolland, ... PLoS Biology 20 (6), e3001659, 2022 | 5 | 2022 |
| B41 HD on chip: Reconstituting the cortico-striatal network on microfluidics to study intracellular trafficking and synaptic transmission A Virlogeux, M Cazorla, J Bruyère, W Christaller, A Genoux, B Charlot, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (Suppl 1), A23-A24, 2016 | 3 | 2016 |
| An integrated microelectrode array and microfluidic platform for stimulating and recording reconstructed neuronal networks E Moutaux, B Charlot, F Bardin, F Saudou, M Cazorla 21st International Conference on Miniaturized Systems for Chemistry and Life …, 2017 | 2 | 2017 |
| TrkB POSITIVE ALLOSTERIC MODULATORS D Rognan, M Schmitt, M Cazorla US Patent App. 17/633,617, 2022 | | 2022 |
| ALG-2 interacting protein-X (Alix) is required for activity-dependent bulk endocytosis at brain synapses MH Laporte, KI Chi, LC Caudal, N Zhao, M Rolland, ... bioRxiv, 2020.07. 20.211854, 2020 | | 2020 |
| Acute and chronic intervention with a TrkB receptor agonist rescues spatial memory deficits in an Alzheimer’s disease mouse model M Levy, A Iatrou, N Van Goethem, M Cazorla, DLA Van den Hove, ... European Neuropsychopharmacology 2 (26), S296, 2016 | | 2016 |
Christoph KellendonkColumbia UniversityAdresse e-mail validée de cumc.columbia.edu
